Monte Rosa Therapeutics Inc Sustainability Reports
Monte Rosa Therapeutics, Inc. is a clinical-stage biotechnology company focused on developing highly selective molecular glue degrader medicines. The company targets undruggable proteins for the treatment of oncology, autoimmune, and inflammatory diseases.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
FIGI: BBG00X2VGZR2
2 reports from 2021 to 2023
Company Profile
Monte Rosa Therapeutics, Inc. is a clinical-stage biotechnology company focused on developing highly selective molecular glue degrader medicines. The company targets undruggable proteins for the treatment of oncology, autoimmune, and inflammatory diseases.
Reports
2 total
Limited sustainability disclosure available
This company only publishes Annual Reports without dedicated sustainability sections.
